From: Echocardiographic AV-interval optimization in patients with reduced left ventricular function
Characteristics | Group 1 (EF > 35%) (n = 10) | Group 2 (EF < 35%) (n = 10) |
---|---|---|
Age | 68.5 ± 4.5 | 65.7 ± 6.3 |
Male sex (%) | 60 | 100 |
Left ventricular ejection fraction (%) | 58 ± 9.7 | 22 ± 7.4 |
Left ventricular end-diastolic dimension (mm) | 47 | 61 |
Coronary artery disease (%) | 30 | 50 |
Dilated cardiomyopathy (%) | 0 | 50 |
Hypertension (%) | 30 | 0 |
Pharmacologic therapy (%) | ||
ACE inhibitor | 40 | 100 |
Beta-blocker | 50 | 90 |
Loop diuretic | 0 | 100 |
Spironolactone | 0 | 70 |